Literature DB >> 8205405

Consistency of morning stiffness: an analysis of diary data.

J M Hazes1, R Hayton, J Burt, A J Silman.   

Abstract

This study aimed to determine the within-individual daily variation in morning stiffness (MS) of RA patients, and to validate the routine clinically derived duration of MS against that recorded prospectively by patients. Forty-nine RA patients, who during a detailed clinical interview reported experiencing MS that week were studied. They were asked to prospectively record, using a diary, daily information on the duration of their MS. The times both of waking and of getting up were noted, as well as the times to first improvement, maximum improvement and complete disappearance of MS, providing six possible estimates of MS duration, three of which, using waking as starting points, could be compared with the interview. The daily variation of MS was assessed by the within-patient range. The median duration of the diary scores was then compared with the MS estimates recorded at the interview. There was a large intra-individual variation in duration of MS, whichever of the six definitions were used. Half of the patients recorded ranges of MS scores of 3 h or more within the same week. There was also marked variation between the median diary derived duration and that ascertained by interview. This variation was at its smallest when the duration of MS was calculated as time until maximum improvement. The routine recording of the 'typical' duration of MS seems to have little clinical value in the face of the large within-patient variation. Of the possible choices for estimating duration, the time from waking to maximum improvement appeared to be the best indicator of the average duration of MS in RA patients.

Entities:  

Mesh:

Year:  1994        PMID: 8205405     DOI: 10.1093/rheumatology/33.6.562

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  3 in total

1.  "Stiffness has different meanings, I think, to everyone": examining stiffness from the perspective of people living with rheumatoid arthritis.

Authors:  Ana-Maria Orbai; Katherine C Smith; Susan J Bartlett; Elaine De Leon; Clifton O Bingham
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-11       Impact factor: 4.794

2.  Anticyclic citrullinated peptide antibody and rheumatoid factor in south Tunisian patients with rheumatoid arthritis: association with disease activity and severity.

Authors:  Mariem Ben Hamad; Sameh Marzouk; Neila Kaddour; Hatem Masmoudi; Faiza Fakhfakh; Ahmed Rebai; Zouhir Bahloul; Abdellatif Maalej
Journal:  J Clin Lab Anal       Date:  2013-12-27       Impact factor: 2.352

Review 3.  Measurement of stiffness in patients with rheumatoid arthritis in low disease activity or remission: a systematic review.

Authors:  Lilian H D van Tuyl; Willem F Lems; Maarten Boers
Journal:  BMC Musculoskelet Disord       Date:  2014-01-29       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.